![Oramed Pharmaceuticals Inc. logo](/logos/ORMP.webp)
Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
Overview | Financials
Company Name | Oramed Pharmaceuticals Inc. |
Symbol | ORMP |
Currency | USD |
Price | 2.35 |
Market Cap | 95,807,150 |
Dividend Yield | 0% |
52-week-range | 1.67 - 3.67 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Nadav Kidron Esq. |
Website | https://www.oramed.com |
An error occurred while fetching data.
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD